| |
| |
|
| Insider
Information: |
Aghazadeh Behzad |
| Relationship: |
10% Owner |
| City: |
New York |
| State: |
NY |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
0 |
|
|
Indirect Shares
|
40,463,516 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$2,873,902,516 |
|
|
| Total
Shares |
40,463,516 |
|
|
| Total
Value |
$2,873,902,516 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
1
|
0
|
|
Stock
price went up :
|
1
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
1.0
|
0.0
|
| Percentage
Gain/Loss : |
 189.2%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Immunomedics Inc |
IMMU |
Director |
2017-11-14 |
0 |
2020-05-01 |
26,363,516 |
Premium* |
|
|
Mirati Therapeutics, Inc. |
MRTX |
10% Owner |
2017-11-16 |
0 |
2019-07-23 |
3,800,000 |
Premium* |
|
|
Cymabay Therapeutics, Inc. |
CBAY |
10% Owner |
|
0 |
2020-08-03 |
10,300,000 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
24 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| CBAY |
Cymabay Therapeutics, Inc... |
10% Owner |
– – • |
2020-08-03 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
10,300,000 |
|
% |
|
| IMMU |
Immunomedics Inc |
Director |
– • – |
2020-05-01 |
4 |
B |
$28.50 |
$49,875,000 |
I/I |
1,750,000 |
26,250,000 |
2.1 |
% |
|
| IMMU |
Immunomedics Inc |
Director |
– • – |
2019-12-05 |
4 |
B |
$17.50 |
$35,000,000 |
I/I |
2,000,000 |
24,500,000 |
2.1 |
- |
|
| IMMU |
Immunomedics Inc |
See Remarks |
– • • |
2019-10-03 |
4 |
B |
$14.10 |
$7,050,000 |
I/I |
500,000 |
22,500,000 |
2.25 |
- |
|
| IMMU |
Immunomedics Inc |
See Remarks |
– • • |
2019-10-02 |
4 |
B |
$13.23 |
$13,230,000 |
I/I |
1,000,000 |
22,000,000 |
2.25 |
- |
|
| MRTX |
Mirati Therapeutics, Inc. |
10% Owner |
– – • |
2019-07-23 |
4 |
S |
$101.88 |
$6,367,500 |
I/I |
(62,500) |
3,800,000 |
0 |
- |
|
| IMMU |
Immunomedics Inc |
See Remarks |
– • • |
2019-06-28 |
4 |
B |
$13.84 |
$3,460,000 |
I/I |
250,000 |
21,000,000 |
2.25 |
- |
|
| IMMU |
Immunomedics Inc |
See Remarks |
– • • |
2019-06-27 |
4 |
B |
$13.68 |
$4,788,000 |
I/I |
350,000 |
20,750,000 |
2.25 |
- |
|
| IMMU |
Immunomedics Inc |
See Remarks |
– • • |
2019-06-26 |
4 |
B |
$13.25 |
$5,300,000 |
I/I |
400,000 |
20,400,000 |
2.25 |
- |
|
| IMMU |
Immunomedics Inc |
See Remarks |
– • • |
2019-06-05 |
4 |
B |
$12.47 |
$3,117,500 |
I/I |
250,000 |
20,000,000 |
2.25 |
- |
|
| IMMU |
Immunomedics Inc |
See Remarks |
– • • |
2019-06-04 |
4 |
B |
$12.10 |
$6,050,000 |
I/I |
500,000 |
19,750,000 |
2.25 |
- |
|
| IMMU |
Immunomedics Inc |
See Remarks |
– • • |
2019-06-03 |
4 |
B |
$12.19 |
$9,575,720 |
I/I |
785,539 |
19,250,000 |
2.25 |
- |
|
| MRTX |
Mirati Therapeutics, Inc. |
10% Owner |
– – • |
2019-03-20 |
4 |
S |
$72.80 |
$1,731,257 |
I/I |
(23,781) |
3,862,500 |
0 |
- |
|
| MRTX |
Mirati Therapeutics, Inc. |
10% Owner |
– – • |
2019-03-19 |
4 |
S |
$73.43 |
$7,343,000 |
I/I |
(100,000) |
3,886,281 |
0 |
- |
|
| MRTX |
Mirati Therapeutics, Inc. |
10% Owner |
– – • |
2019-03-18 |
4 |
S |
$76.55 |
$9,568,750 |
I/I |
(125,000) |
3,986,281 |
0 |
- |
|
| MRTX |
Mirati Therapeutics, Inc. |
10% Owner |
– – • |
2019-02-20 |
4 |
S |
$73.00 |
$50,137,860 |
I/I |
(686,820) |
4,111,281 |
0 |
- |
|
| IMMU |
Immunomedics Inc |
See Remarks |
– • • |
2018-06-15 |
4 |
B |
$23.39 |
$4,678,000 |
I/I |
200,000 |
17,714,461 |
2.25 |
- |
|
| IMMU |
Immunomedics Inc |
See Remarks |
– • • |
2018-06-15 |
4 |
B |
$24.00 |
$13,800,000 |
I/I |
575,000 |
17,514,461 |
2.25 |
- |
|
| MRTX |
Mirati Therapeutics, Inc. |
10% Owner |
– – • |
2018-06-11 |
4 |
B |
$38.85 |
$15,540,000 |
I/I |
400,000 |
4,798,101 |
1.5 |
- |
|
| IMMU |
Immunomedics Inc |
See Remarks |
– • • |
2018-02-16 |
4 |
OE |
$7.00 |
$6,125,000 |
I/I |
875,000 |
16,939,461 |
0 |
- |
|
| MRTX |
Mirati Therapeutics, Inc. |
10% Owner |
– – • |
2017-11-16 |
4 |
OE |
$7.86 |
$294,750 |
I/I |
37,500 |
4,398,101 |
0 |
- |
|
| MRTX |
Mirati Therapeutics, Inc. |
10% Owner |
– – • |
2017-11-16 |
4 |
B |
$13.00 |
$8,450,000 |
I/I |
650,000 |
4,360,601 |
1.5 |
- |
|
| IMMU |
Immunomedics Inc |
See Remarks |
– • • |
2017-11-15 |
4 |
B |
$10.97 |
$1,919,750 |
I/I |
175,000 |
16,064,461 |
2.25 |
- |
|
| IMMU |
Immunomedics Inc |
See Remarks |
– • • |
2017-11-14 |
4 |
B |
$10.39 |
$11,948,500 |
I/I |
1,150,000 |
15,889,461 |
2.25 |
- |
|
24 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
